Guideline compliance for bridging anticoagulation use in vitamin-K antagonist patients; practice variation and factors associated with non-compliance

Table 3 Compliance of postoperative bridging per indication and AT9 thromboembolic risk group

	Compliance of postoperative bridging per indication group: n(%) ^a
AT9 Thromboembolic risk	Atrial fibrillation	Mechanical heart valve	Venous thromboembolism
Low	88 (67)	0 (0)	3 (50)
Moderate	19 (100)	4 (100)	22 (100)
High	16 (46)	5 (56)	3 (75)

AT9: Antithrombotic Therapy and Prevention of Thrombosis, Ninth Edition guideline; VKA: vitamin-K antagonist
^a Multiple indications are possible

ISSN: 1477-9560